MedTrace Logo

Laser Therapy on Hamstring Muscle Among Young Adults

NCT05077761 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2023-10-10

No results posted yet for this study

Summary

A total of 154 healthy young individuals will be recruited by purposive sampling method to participate in a randomized, single-blinded, sham-controlled study. Recruited participants will be randomly dividing into two groups, the Active high-intensity laser therapy (a-HILT) group, and the Sham high-intensity laser therapy (s-HILT) group. The treatment duration will be 10 minutes per session on both lower limbs for each day for 3 days/week for 2 weeks. Hamstring muscle length will be assessed at baseline, end of the 2-week post-intervention period.

Conditions

  • Muscle Tightness

Interventions

DEVICE

Active High-intensity laser therapy

High-intensity laser therapy will be used in the contact method, with the laser beam irradiated over the hamstring muscle. Dosage and parameters for the laser will be calculated. Parameters- 1. Wavelength- 980 nm 2. Intensity/Power density- 3W/cm2 3. Emission mode- Continuous Emission 4. Energy (Joules)- 490 J 5. Irradiation time- 70 Sec on each point 6. Peak power- 15 Watt 7. Irradiation points- 09

DEVICE

Sham High-intensity laser therapy

Sham High-intensity laser therapy will be used in the contact method, without the laser beam irradiation over the hamstring muscle.

Sponsors & Collaborators

  • Maharishi Markendeswar University (Deemed to be University)

    lead OTHER

Principal Investigators

  • Adarsh K Srivastav, PhD Scholar · MMIPR, MM(DU)

  • Asir J Samuel, PhD · MMIPR, MM(DU)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-08-19
Completion
2023-10-09

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05077761 on ClinicalTrials.gov